SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bacher Dror

(Last)

(First)

(Middle)

9 HALAMISH STREET

(Street)

CAESAREA INDUSTRIAL PARK

3088900

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/25/2017

3. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp. [ DRIO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	102,474	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽¹⁾	01/06/2024	Common Stock	1,334	$166.5	D
Employee Stock Option (right to buy)	⁽²⁾	07/07/2024	Common Stock	1,334	$88.2	D
Employee Stock Option (right to buy)	⁽³⁾	09/03/2021	Common Stock	25,338	$5.76	D
Employee Stock Option (right to buy)	⁽⁴⁾	12/17/2021	Common Stock	9,584	$7.02	D
Employee Stock Option (right to buy)	⁽⁵⁾	01/30/2023	Common Stock	27,492	$3.202	D
Common Stock Purchase Warrant	07/23/2015	07/23/2018	Common Stock	278	$7.2	D

Explanation of Responses:

1. The option vested in 8 equal quarterly installments beginning on April 7, 2014.

2. The option vested in 8 equal quarterly installments beginning on October 7, 2014.

3. The option vests 33% on the September 3, 2015 and the balance in 8 equal instalments beginning on December 3, 2015.

4. The option vests 33% after one year and the balance in 8 equal instalments beginning on March 17, 2017.

5. The option vests in 12 equal quarterly instalments beginning on April 30, 2017.

	/s/ Dror Bacher	07/26/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.